Clinical Trials
53 trialsMulticenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:
Xiangya Hospital of Central South University
CSF-IMR
Medical University of Warsaw
BRAIN MATRIX
University of Birmingham
ResPGlioma
Universita degli Studi di Genova
LGG PRO's
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Targeted Pediatric High-Grade Glioma Therapy
Nationwide Children's Hospital
Clinical, patHOlogical and Imaging Project of nEuro-oncology (HOPE)
Beijing Tiantan Hospital
SC-Het-GM-CCS
The Children's Hospital of Zhejiang University School of Medicine
Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma
M.D. Anderson Cancer Center
Improve TMZ
University College Cork
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
M.D. Anderson Cancer Center
NEMO
Tata Memorial Centre
Construction and Application of an IDH Mutation-Targeted PET/MRI Imaging Framework for Precision Diagnosis of Gliomas
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Mapping of Electrical Properties in the Brain
Mayo Clinic
Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases
Tianjin Medical University
HiLoGlio
Maastricht Radiation Oncology
VIOLETA
iOMEDICO AG
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification
European Organisation for Research and Treatment of Cancer - EORTC
FESS
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
neGLIO
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Prospective Real-World Study of Pathology AI for Glioma Molecular Prediction
Nanfang Hospital, Southern Medical University
Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas
OHSU Knight Cancer Institute
AI-assisted Diagnosis of Malignant Brain Tumors
Second Affiliated Hospital, School of Medicine, Zhejiang University
ReGIT
Indiana University
APPEAR
LMU Klinikum
Multi-Dimensional MRI Spatial Heterogeneity Analysis for Predicting Key Genes and Prognosis of High-Grade Gliomas: A Multi-Center Study
RenJi Hospital
Glioma Developmental and HyperActive Ras Tumor (DHART) Board
Memorial Sloan Kettering Cancer Center
BIO-RIN
Tata Memorial Centre
GLIO-RAD
Tata Memorial Centre
AI-RAD
Tata Memorial Centre
Glioma2015
Universitaire Ziekenhuizen KU Leuven
INSANE
Fondazione IRCCS Policlinico San Matteo di Pavia
Three miRNA Signatures in Glioma: From Molecular Mechanisms to Potential Clinical Application
Regina Elena Cancer Institute
VASIM
Leiden University Medical Center
DT-MiNi
Beijing Tiantan Hospital
ATM GBM
Kuopio University Hospital
FASTMRSI
Insel Gruppe AG, University Hospital Bern
SOPRANO
Erasmus Medical Center
GLIO-AI
Centro di Riferimento Oncologico - Aviano
GLIBAMIR
University Hospital, Caen
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
University of California, San Diego
Brain Glioma Registry Combining Clinical and Imaging Information
Asan Medical Center
SUPRAMAX
Erasmus Medical Center
GliomiR
University Hospital, Caen
The Role of B7-H4 in Tumor Vaccine
Huashan Hospital
Tumor Vaccines for Solid Tumors
Huashan Hospital
circTeloDIAG
Hospices Civils de Lyon
LoG-Glio
University of Ulm
GRIPP
Beijing Tiantan Hospital
MR Based Survival Prediction of Glioma Patients Using Artificial Intelligence
The First Affiliated Hospital of Zhengzhou University